During the past decade, Kaiser Permanente Vaccine Study Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Vaccine Study Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "MassBiologics" with 1 trials sponsored, "MedImmune LLC" with 1 trials sponsored and "Novartis Vaccines" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Vaccine Study Center" #1 collaborator was "Kaiser Permanente" with 2 trials as a collaborator and "Medarex" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Vaccine Study Center" are "Smallpox" (2 trials), "Clostridium Infections" (1 trials), "Human Influenza" (1 trials), "Influenza" (1 trials) and "Invasive Pneumococcal Disease" (1 trials). Many other conditions were trialed in "Kaiser Permanente Vaccine Study Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Vaccine Study Center" are "Biological" (8 trials), "Other" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "GS-CDA1/MDX-1388" (1 trials), "Inactivated Influenza Vaccine" (1 trials) and "Liquid CAIV-T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Vaccine Study Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Kaiser Permanente Vaccine Study Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Kaiser Permanente Vaccine Study Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Vaccine Study Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".